Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 252

1.

High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds.

Zampieri M, Szappanos B, Buchieri MV, Trauner A, Piazza I, Picotti P, Gagneux S, Borrell S, Gicquel B, Lelievre J, Papp B, Sauer U.

Sci Transl Med. 2018 Feb 21;10(429). pii: eaal3973. doi: 10.1126/scitranslmed.aal3973.

PMID:
29467300
2.

B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis.

Bénard A, Sakwa I, Schierloh P, Colom A, Mercier I, Tailleux L, Jouneau L, Boudinot P, Al-Saati T, Lang R, Rehwinkel J, Loxton AG, Kaufmann SHE, Anton-Leberre V, O'Garra A, Sasiain MDC, Gicquel B, Fillatreau S, Neyrolles O, Hudrisier D.

Am J Respir Crit Care Med. 2018 Mar 15;197(6):801-813. doi: 10.1164/rccm.201707-1475OC.

PMID:
29161093
3.

MmpS5/MmpL5 as an efflux pump in Mycobacterium species.

Briffotaux J, Huang W, Wang X, Gicquel B.

Tuberculosis (Edinb). 2017 Dec;107:13-19. doi: 10.1016/j.tube.2017.08.001. Epub 2017 Aug 4. Review.

PMID:
29050760
4.

Ionophore A23187 shows anti-tuberculosis activity and synergy with tebipenem.

Huang W, Briffotaux J, Wang X, Liu L, Hao P, Cimino M, Buchieri MV, Namouchi A, Ainsa JA, Gicquel B.

Tuberculosis (Edinb). 2017 Dec;107:111-118. doi: 10.1016/j.tube.2017.09.001. Epub 2017 Sep 6.

PMID:
29050757
5.

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids.

Blanc L, Gilleron M, Prandi J, Song OR, Jang MS, Gicquel B, Drocourt D, Neyrolles O, Brodin P, Tiraby G, Vercellone A, Nigou J.

Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11205-11210. doi: 10.1073/pnas.1707840114. Epub 2017 Oct 2.

6.

Nitazoxanide Analogs Require Nitroreduction for Antimicrobial Activity in Mycobacterium smegmatis.

Buchieri MV, Cimino M, Rebollo-Ramirez S, Beauvineau C, Cascioferro A, Favre-Rochex S, Helynck O, Naud-Martin D, Larrouy-Maumus G, Munier-Lehmann H, Gicquel B.

J Med Chem. 2017 Sep 14;60(17):7425-7433. doi: 10.1021/acs.jmedchem.7b00726. Epub 2017 Aug 28.

PMID:
28846409
7.

Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery.

Namouchi A, Cimino M, Favre-Rochex S, Charles P, Gicquel B.

BMC Genomics. 2017 Jul 13;18(1):530. doi: 10.1186/s12864-017-3924-y.

8.

Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis.

Nascimento IP, Rodriguez D, Santos CC, Amaral EP, Rofatto HK, Junqueira-Kipnis AP, Gonçalves EDC, D'Império-Lima MR, Hirata MH, Silva CL, Winter N, Gicquel B, Mills KHG, Pizza M, Rappuoli R, Leite LCC.

Sci Rep. 2017 May 18;7(1):2109. doi: 10.1038/s41598-017-02003-9.

9.

Use of GeneXpert Remnants for Drug Resistance Profiling and Molecular Epidemiology of Tuberculosis in Libreville, Gabon.

Alame-Emane AK, Pierre-Audigier C, Aboumegone-Biyogo OC, Nzoghe-Mveang A, Cadet-Daniel V, Sola C, Djoba-Siawaya JF, Gicquel B, Takiff HE.

J Clin Microbiol. 2017 Jul;55(7):2105-2115. doi: 10.1128/JCM.02257-16. Epub 2017 Apr 26.

10.

Experimental infection of New Zealand Merino sheep with a suspension of Mycobacterium avium subspecies paratuberculosis (Map) strain Telford: Kinetics of the immune response, histopathology and Map culture.

Dukkipati VSR, Ridler AL, Thompson KG, Buddle BM, Hedgespeth BA, Price-Carter M, Begg DJ, Whittington RJ, Gicquel B, Murray A.

Vet Microbiol. 2016 Nov 15;195:136-143. doi: 10.1016/j.vetmic.2016.09.018. Epub 2016 Sep 23.

11.

Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination.

Polena H, Boudou F, Tilleul S, Dubois-Colas N, Lecointe C, Rakotosamimanana N, Pelizzola M, Andriamandimby SF, Raharimanga V, Charles P, Herrmann JL, Ricciardi-Castagnoli P, Rasolofo V, Gicquel B, Tailleux L.

Sci Rep. 2016 Sep 12;6:33162. doi: 10.1038/srep33162.

12.

Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China.

Xu P, Wu J, Yang C, Luo T, Shen X, Zhang Y, Nsofor CA, Zhu G, Gicquel B, Gao Q.

Tuberculosis (Edinb). 2016 May;98:56-61. doi: 10.1016/j.tube.2016.02.008. Epub 2016 Mar 3.

13.

In reply.

Takiff H, Alame-Emane AK, Pierre-Audigier C, Gicquel B.

Int J Tuberc Lung Dis. 2016 Feb;20(2):282-3. doi: 10.5588/ijtld.15.0628-2. No abstract available.

PMID:
26792487
14.

Bacterial infection remodels the DNA methylation landscape of human dendritic cells.

Pacis A, Tailleux L, Morin AM, Lambourne J, MacIsaac JL, Yotova V, Dumaine A, Danckaert A, Luca F, Grenier JC, Hansen KD, Gicquel B, Yu M, Pai A, He C, Tung J, Pastinen T, Kobor MS, Pique-Regi R, Gilad Y, Barreiro LB.

Genome Res. 2015 Dec;25(12):1801-11. doi: 10.1101/gr.192005.115. Epub 2015 Sep 21.

15.

Biomarkers for risk of developing active tuberculosis in contacts of TB patients: a prospective cohort study.

Rakotosamimanana N, Richard V, Raharimanga V, Gicquel B, Doherty TM, Zumla A, Rasolofo Razanamparany V.

Eur Respir J. 2015 Oct;46(4):1095-103. doi: 10.1183/13993003.00263-2015. Epub 2015 Aug 6.

16.

Ecto-5'-Nucleotidase (CD73) Deficiency in Mycobacterium tuberculosis-Infected Mice Enhances Neutrophil Recruitment.

Petit-Jentreau L, Jouvion G, Charles P, Majlessi L, Gicquel B, Tailleux L.

Infect Immun. 2015 Sep;83(9):3666-74. doi: 10.1128/IAI.00418-15. Epub 2015 Jul 6.

17.

Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.

Alame-Emane AK, Xu P, Pierre-Audigier C, Cadet-Daniel V, Shen X, Sraouia M, Siawaya JF, Takiff H, Gao Q, Gicquel B.

Int J Tuberc Lung Dis. 2015 Jun;19(6):679-84. doi: 10.5588/ijtld.14.0768.

PMID:
25946359
18.

bacterial infection drives the expression dynamics of microRNAs and their isomiRs.

Siddle KJ, Tailleux L, Deschamps M, Loh YH, Deluen C, Gicquel B, Antoniewski C, Barreiro LB, Farinelli L, Quintana-Murci L.

PLoS Genet. 2015 Mar 20;11(3):e1005064. doi: 10.1371/journal.pgen.1005064. eCollection 2015 Mar. Erratum in: PLoS Genet. 2015 Jun;11(6):e1005321.

19.

Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice.

Solans L, Uranga S, Aguilo N, Arnal C, Gomez AB, Monzon M, Badiola JJ, Gicquel B, Martin C.

Vaccine. 2014 Sep 8;32(40):5192-7. doi: 10.1016/j.vaccine.2014.07.047. Epub 2014 Jul 25.

PMID:
25066740
20.

Extracellular adenosine triphosphate affects the response of human macrophages infected with Mycobacterium tuberculosis.

Dubois-Colas N, Petit-Jentreau L, Barreiro LB, Durand S, Soubigou G, Lecointe C, Klibi J, Rezaï K, Lokiec F, Coppée JY, Gicquel B, Tailleux L.

J Infect Dis. 2014 Sep 1;210(5):824-33. doi: 10.1093/infdis/jiu135. Epub 2014 Mar 5.

PMID:
24604822

Supplemental Content

Loading ...
Support Center